News

Filter

Current filters:

None

7885 to 7894 of 97511 results

Japan's vulnerable pharma companies, by P Reed Maurer

12-09-2012

Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

French price regulator authorizes reimbursement of InterMune's Esbriet

12-09-2012

USA-based InterMune (Nasdaq: ITMN) says that French regulator the Comite Economique des Produits de…

EsbrietEuropeInterMunePharmaceuticalPricingRespiratory and Pulmonary

Zalicus drops Synavive RA drug after disappointing Ph IIb results

12-09-2012

US biotech firm Zalicus (Nasdaq: ZLCS) saw its shares plunge nearly 40% to $0.84 in afternoon trading…

Anti-Arthritics/RheumaticsBiotechnologyResearchSynaviveZalicus

Summit licenses Seglin technology to Bristol-Myers

12-09-2012

UK drug discovery firm Summit Pharmaceuticals (AIM: SUMM) has entered a technology license agreement…

Bristol-Myers SquibbLicensingPharmaceuticalResearchSummit Pharmaceuticals

Resubmission of aripiprazole NDA accepted; AstraZeneca bond issue

12-09-2012

Danish CNS-focused drugmaker Lundbeck (LUND: DC) and Japanese partner Otsuka Pharmaceutical (TYO: 4668)…

aripiprazole depotAstraZenecaFinancialLundbeckNeurologicalNorth AmericaOtsukaPharmaceuticalRegulation

Cell Therapeutics initiates launch of Pixuvri in Europe

12-09-2012

Following the European approval of the drug this spring (The Pharma Letter May 14), US biotech firm Cell…

BiotechnologyCell TherapeuticsEuropeMarkets & MarketingOncologyPixuvriRare diseases

Swiss biotech Actelion implements cost saving initiative

11-09-2012

Switzerland-based Actelion (SIX: ATLN), Europe's largest biotech company, says that it has now concluded…

ActelionBiotechnologyFinancialManagement

India's patent laws under pressure, say UK researchers

11-09-2012

In a special report in the prestigious medical journal The Lancet, researchers from Queen Mary, University…

Asia-PacificBayerEuropeGenericsLegalNovartisPatentsPharmaceutical

FDA delays approval of Navidea's Lymphoseek

11-09-2012

US biotech company Navidea Biopharmaceuticals (NYSE: NAVB) says it has received a Complete Response Letter…

BiotechnologyLymphoseekNavidea BiopharmaceuticalsNorth AmericaRegulation

7885 to 7894 of 97511 results

Back to top